Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part…

GuidelineReumatologia clinica· May 2026

Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension.

Karla Chacón-Abril, Margarita Portela-Hernández, Luis Daniel Fajardo-Hermosillo … Systemic Sclerosis Guidelines Committee of the Colegio Mexicano de Reumatología

Read paper

RheumatologyGuidelineClinical practiceQ3IF 1.3

New national guidelines for systemic sclerosis treatment achieved high consensus.

Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension.

Karla Chacón-Abril … Systemic Sclerosis Guidelines Committee of the Colegio Mexicano de Reumatología

Reumatologia clinica · May 2026

Background

Systemic sclerosis (sclerosis) is a severe autoimmune disease characterized by fibrosis, inflammation, and vasculopathy, with high morbidity and mortality.

≥80% acceptance

Results

≥80% acceptance

most experts accepted the new treatment recommendations

n = 594 records

More results

Of 594 records identified, 114 studies were ultimately included after evaluation using the GRADE methodology.

“

Conclusion

A total of 26 recommendations were issued and subjected to Delphi consensus, with agreement defined as ≥80% acceptance.

Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension.

Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension.

Related papers